The Hepatitis B Foundation’s Baruch S. Blumberg Institute Hosts the 13th Annual Regional Biotech Conference

Share Article

The Hepatitis B Foundation’s Baruch S. Blumberg Institute will host the 13th Annual Regional Biotech Conference, themed “Consumer Product Development, an Alternative Path to Commercialization.”

“Consumer Product Development, an Alternative Path to Commercialization”

Date: Friday, Nov. 15, 2013

Time: 8 a.m. – 1 p.m.

Location: Pennsylvania Biotechnology Center, 3805 Old Easton Road, Doylestown, Pa.

Details: The Hepatitis B Foundation’s Baruch S. Blumberg Institute will host the 13th Annual Regional Biotech Conference, themed “Consumer Product Development, an Alternative Path to Commercialization.” More than 120 of the area’s life science and biotechnology leaders will assemble at the PA Biotechnology Center to hear local biotech founders and executives share their success stories and insights about growing biotech opportunities.

The following speakers and topics will be featured during the conference:

•Timothy Block, Ph.D., President, PA Biotechnology Center, Hepatitis B Foundation an Baruch S. Blumberg Institute; Professor, Drexel University College of Medicine

•William Kinney, Ph.D., Director, Regional Biotech Council; Keystone Innovation Zone (KIZ) Coordinator, PA Biotechnology Center of Bucks County

•Maxwell Stock, President & CEO, Signum Biosciences, Inc. – “Straddling the Fence Between Rx and Consumer Product Development”

•Dave Hamlin, DMD, Managing Partner, Transcidental – “Rapid and Robust Return on Investment in Natural Product Based Products”

•John Lyga, Director, Bioscience and Strategic Alliance, Avon – “The Art, Science, and Regulations of Personal Care Product Development”

•Miri Seiberg, PhD, Seiberg Consulting, formerly with Johnson & Johnson Skin Research Center – “Non-Denatured Soybean Extracts for Skin Care: Continuous Success at 13 Years After Launch”

About the Regional Biotech Council (RBC): The RBC is a program of the Baruch S. Blumberg Institute, the research affiliate of the Hepatitis B Foundation, and funded in part by grants from the Commonwealth of Pennsylvania. The mission of the RBC is to provide a stimulating networking environment and strategic support for biotech entrepreneurs within the five-county region of southeastern Pennsylvania – Chester, Montgomery, Delaware, Philadelphia and Bucks. To learn more, go to http://www.blumberginstitute.org/.

About the Baruch S. Blumberg Institute: Formerly the Institute for Hepatitis and Virus Research, the Baruch S. Blumberg Institute is an independent nonprofit research center established in 2003 by the Hepatitis B Foundation to conduct discovery research and nurture translational biotechnology in an environment conducive to interaction, collaboration and focus. To learn more, go to http://www.blumberginstitute.org/.

About the Hepatitis B Foundation: Headquartered in Doylestown, Pa., the Hepatitis B Foundation is the only national nonprofit organization solely dedicated to finding a cure for hepatitis B and improving the quality of life for those affected worldwide through research, education and patient advocacy. To learn more, go to http://www.hepb.org, read our blog at http://wp.hepb.org, follow us on Twitter @HepBFoundation, find us on Facebook at http://www.facebook.com/hepbfoundation or call (215) 489-4900.

Contact: Sarah Larson at sarah(at)furiarubel(dot)com or 215-340-0480

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sarah Larson
Follow us on
Visit website